BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully integrated biopharmaceutical company, announced that CEO Seth Lederman, M.D., will present at the 2025 ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...
Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced promising ...
TScan Therapeutics is developing TSC-101 and multiplex TCR-Ts for cancer treatment. See why TCRX stock holds potential with ...
Tonix Pharmaceuticals (NASDAQ: TNXP) announced that CEO Seth Lederman, M.D., will present at the Zacks SCR Life Sciences Virtual Investor Forum on Ma ...
3d
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that Seth Lederman M.D ...
Jan. 16, 2025 — Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials ... New Innovative Local ...
After hours: March 12 at 7:59:58 PM EDT Loading Chart for TNXP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback